New biopharmaceutical discoveries and innovations are creating excitement as well as challenges for practitioners looking to construct appropriate IP protection. Please join Gary C. Ma, Amanda K. Murphy, Ph.D., Barbara R. Rudolph, Ph.D. and Michael Liu Su for a briefing on new biopharma hot topics. The program will take place at Le Meridien Taipei in Taipei, Taiwan. For more information, or to register, please click here.
Articles
California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data
June 4, 2026
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.